Text 2014_Text.qxd 7/21/2014 3:22 PM Page 369
MISCELLANEOUS LAWS 369
MISCELLANEOUS LAWS Mesterolone Metenolone LEGEND DRUGS; ANABOLIC Methandienone STEROIDS Methandro stenolone Methyltestosterone TITLE 16 Nandrolone decanoate Nandrolone phenpropionate ARTICLE 18 Norethandrolone Oxandrolone Chapter 2. Definitions [Portions omitted]. Oxymesterone 16-18-2-5.5. “Adult stem cell” defined. Oxymetholone 16-18-2-15. “Anabolic steroid” defined. Stanozolol 16-18-2-56.5. “Cloning” defined. Testosterone propionate 16-18-2-78. “Controlled premises” defined. Testosterone-like related compounds. 16-18-2-79. “Controlled substance” defined. 16-18-2-101. “Drug” defined. 16-18-2-56.5. “Cloning” defined. 16-18-2-102. “Drug order” defined. (a) “Cloning” means the use of asexual repro- 16-18-2-103. “Drug sample” defined. duction to create or grow a human embryo from 16-18-2-128.5. “Fetal stem cell” defined. a single cell or cells of a genetically identical 16-18-2-183.5. “Human embryo” defined. human. 16-18-2-194. “Investigational or new drug” defined. (b) The term does not include: 16-18-2-199. “Legend drug” defined. (1) a treatment or procedure to enhance 16-18-2-216. “Manufacturer” defined. human reproductive capability through the 16-18-2-223. “Mechanical device” defined. manipulation of human oocytes or 16-18-2-281. “Pharmacist” defined. embryos, including the following: 16-18-2-288. “Practitioner” defined. (A) In vitro fertilization. 16-18-2-289. “Precursor” defined. (B) Gamete intrafallopian transfer. 16-18-2-292. “Prescription” defined. 16-18-2-321. “Sale” defined. (C) Zygote intrafallopian transfer; or 16-18-2-365. “Viability” defined. (2) the following types of stem cell 16-18-2-374. “Wholesaler” defined. research: (A) Adult stem cell. 16-18-2-5.5. “Adult stem cell” defined. (B) Fetal stem cell, as long as the bio- “Adult stem cell”means an undifferentiated cell logical parent has given written consent that: for the use of the fetal stem cells. (1) is found in a differentiated tissue; (C) Embryonic stem cells from lines (2) is renewable; and that are permissible for use under appli- (3) yields specialized cell types with cer- cable federal law. tain limitations of the tissue from which it originated. 16-18-2-78. “Controlled premises” defined. “Controlled premises,” for purposes of IC 16- 16-18-2-15. “Anabolic steroid” defined. “Anabolic steroid,” ,” for purposes of IC 16- 42-20-2, has the meaning set forth in IC 16-42-20- 42-19, means a material, compound, mixture, or 2(a). preparation that contains an anabolic steroid that 16-18-2-79. “Controlled substance” defined. includes any of the following: “Controlled substance,” for purposes of IC Chorionic gonadotropin 16-42-21, has the meaning set forth in IC 16-42- Clostebol 21-1. Dehydrochlormethyltestosterone Ethylestrenol 16-18-2-101. “Drug” defined. Fluoxymesterone (a) “Drug,” for purposes of IC 16-42-1 through